Glioma clinical trials

Explore recruiting glioma clinical trials.

Recruiting glioma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Glioma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

FIREFLY-1: A Phase 2, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of the Oral Pan-RAF Inhibitor DAY101 in Pediatric Patients with RAF-Altered, Recurrent or Progressive Low-Grade Glioma and Advanced Solid Tumors

Denmark, Netherlands, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

uPAR PET/MRI in glioma

Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication: BIOMEDE 2.0

Denmark, France, Sweden, Spain, Finland, Norway +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

An open randomized phase II clinical trial evaluating the safety and efficacy of rapamycin in the treatment of gliomas high-grade malignant gliomas in children as part of the establishment management of rare and ultra rare diseases of the central nervous system associated with mTOR pathway activation: BraimTOR- ONKO

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Repurposed Drugs in Research and Cancer Clinical Trials. The ReDiReCCT trial Vemurafenib

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Phase IB clinical trial to assess the safety, tolerability, and preliminary efficacy of AloCELYVIR (Mesenchymal allogenic cells + ICOVIR-5) in children, adolescent and young adults with newly diagnosed diffuse intrinsic pointine glioma (DIPG) in combination with radiotherapy or medulloblastoma in relapse/progression in monotherapy.

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Glioma trials by city

Glioma in Toronto Glioma in Vancouver Glioma in Montreal Glioma in Calgary Glioma in Edmonton Glioma in Ottawa Glioma in Winnipeg Glioma in Quebec City Glioma in Hamilton Glioma in Kitchener Glioma in London Glioma in Halifax Glioma in New York Glioma in Los Angeles Glioma in Chicago Glioma in Houston

Glioma clinical trials

Recruiting glioma studies right now

5G-PEARL: Paxalisib in Malignant Brain Tumours

Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease

Combined Treatment of Patients With Newly Diagnosed Glioblastoma Using the Xoft® Axxent® Electronic Brachytherapy (eBx®) System for Intraoperative Balloon Electronic Brachytherapy

Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

ASCENT Intervention for Brain Tumor Patients

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Pilot Trial for Treatment of Recurrent Glioblastoma

Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standard of Care Radiation

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors